A citation-based method for searching scientific literature


List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial.
S L Ellis, E G Moser, J K Snell-Bergeon, A S Rodionova, R M Hazenfield, S K Garg. Diabet Med 2011
89
23

Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study.
K V S Hari Kumar, Altamash Shaikh, Pitambar Prusty. Diabetes Res Clin Pract 2013
61
23


Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes.
Gayatri Sarkar, May Alattar, Rebecca J Brown, Michael J Quon, David M Harlan, Kristina I Rother. Diabetes Care 2014
51
15

A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes.
Benjamin Udoka Nwosu, Louise Maranda, Karen Cullen, Lisa Greenman, Jody Fleshman, Nancy McShea, Bruce A Barton, Mary M Lee. PLoS One 2015
28
15




Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study.
Yunjuan Zhao, Lin Yang, Yufei Xiang, Lingjiao Liu, Gan Huang, Zhaofeng Long, Xia Li, R David Leslie, Xiangbing Wang, Zhiguang Zhou. J Clin Endocrinol Metab 2014
73
15


Vildagliptin reduces glucagon during hyperglycemia and sustains glucagon counterregulation during hypoglycemia in type 1 diabetes.
Johan Farngren, Margaretha Persson, Anja Schweizer, James E Foley, Bo Ahrén. J Clin Endocrinol Metab 2012
63
15

Effects of sitagliptin on counter-regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double-blind placebo-controlled crossover study.
J E Schopman, J B L Hoekstra, B M Frier, M T Ackermans, J J J de Sonnaville, A M Stades, R Zwertbroek, B Hartmann, J J Holst, F K Knop,[...]. Diabetes Obes Metab 2015
13
15

Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.
Satish K Garg, Emily G Moser, Bruce W Bode, Leslie J Klaff, William R Hiatt, Christie Beatson, Janet K Snell-Bergeon. Endocr Pract 2013
66
15

Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low‑density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study.
Paweł Burchardt, Agnieszka Zawada, Piotr Tabaczewski, Dariusz Naskręt, Jolanta Kaczmarek, Justyna Marcinkaniec, Bogna Wierusz-Wysocka, Henryk Wysocki. Pol Arch Med Wewn 2013
17
15

Noninsulin pharmacological management of type 1 diabetes mellitus.
Vishvas Garg. Indian J Endocrinol Metab 2011
7
28

Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial.
Jill Hamilton, Elizabeth Cummings, Vera Zdravkovic, Diane Finegood, Denis Daneman. Diabetes Care 2003
106
15

Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.
Søren Søgaard Lund, Lise Tarnow, Anne Sofie Astrup, Peter Hovind, Peter Karl Jacobsen, Amra Ciric Alibegovic, Ida Parving, Lotte Pietraszek, Merete Frandsen, Peter Rossing,[...]. PLoS One 2008
56
15


Current use of metformin in addition to insulin in pediatric patients with type 1 diabetes mellitus: an analysis based on a large diabetes registry in Germany and Austria.
Katja Konrad, Nicolin Datz, Ilse Engelsberger, Jürgen Grulich-Henn, Thomas Hoertenhuber, Burkhild Knauth, Thomas Meissner, Susanna Wiegand, Joachim Woelfle, Reinhard W Holl. Pediatr Diabetes 2015
19
15



Sugar intake is associated with progression from islet autoimmunity to type 1 diabetes: the Diabetes Autoimmunity Study in the Young.
Molly M Lamb, Brittni Frederiksen, Jennifer A Seifert, Miranda Kroehl, Marian Rewers, Jill M Norris. Diabetologia 2015
32
7

A run on the biobank: what have we learned about type 1 diabetes from the nPOD tissue repository?
John S Kaddis, Alberto Pugliese, Mark A Atkinson. Curr Opin Endocrinol Diabetes Obes 2015
24
7

Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.
Hillary A Keenan, Jennifer K Sun, Jared Levine, Alessandro Doria, Lloyd P Aiello, George Eisenbarth, Susan Bonner-Weir, George L King. Diabetes 2010
311
7

Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes.
Michael J Haller, Stephen E Gitelman, Peter A Gottlieb, Aaron W Michels, Stephen M Rosenthal, Jonathan J Shuster, Baiming Zou, Todd M Brusko, Maigan A Hulme, Clive H Wasserfall,[...]. J Clin Invest 2015
93
7

Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice.
Mark S Freedman, Giancarlo Comi, Nicola De Stefano, Frederik Barkhof, Chris H Polman, Bernard M J Uitdehaag, Lorenz Lehr, Bettina Stubinski, Ludwig Kappos. Mult Scler Relat Disord 2014
44
7

Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency.
E S Husebye, B Allolio, W Arlt, K Badenhoop, S Bensing, C Betterle, A Falorni, E H Gan, A-L Hulting, A Kasperlik-Zaluska,[...]. J Intern Med 2014
184
7

Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes.
Sefina Arif, Pia Leete, Vy Nguyen, Katherine Marks, Nurhanani Mohamed Nor, Megan Estorninho, Deborah Kronenberg-Versteeg, Polly J Bingley, John A Todd, Catherine Guy,[...]. Diabetes 2014
130
7

Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.
Jay M Sosenko, Jay S Skyler, Craig A Beam, Jeffrey P Krischer, Carla J Greenbaum, Jeffrey Mahon, Lisa E Rafkin, Della Matheson, Kevan C Herold, Jerry P Palmer. Diabetes 2013
46
7

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.
Anette G Ziegler, Marian Rewers, Olli Simell, Tuula Simell, Johanna Lempainen, Andrea Steck, Christiane Winkler, Jorma Ilonen, Riitta Veijola, Mikael Knip,[...]. JAMA 2013
523
7

Molecular signatures differentiate immune states in type 1 diabetic families.
Yi-Guang Chen, Susanne M Cabrera, Shuang Jia, Mary L Kaldunski, Joanna Kramer, Sami Cheong, Rhonda Geoffrey, Mark F Roethle, Jeffrey E Woodliff, Carla J Greenbaum,[...]. Diabetes 2014
43
7

General population screening for type 1 diabetes: has its time come?
Richard A Insel, Jessica L Dunne, Anette-G Ziegler. Curr Opin Endocrinol Diabetes Obes 2015
26
7

Adrenal insufficiency.
Wiebke Arlt, Bruno Allolio. Lancet 2003
555
7

Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.
Jacqueline Jonklaas, Antonio C Bianco, Andrew J Bauer, Kenneth D Burman, Anne R Cappola, Francesco S Celi, David S Cooper, Brian W Kim, Robin P Peeters, M Sara Rosenthal,[...]. Thyroid 2014
548
7



Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe.
Ashley Grossman, Gudmundur Johannsson, Marcus Quinkler, Pierre Zelissen. Eur J Endocrinol 2013
68
7


Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm.
Venkat Sasidhar Renukuntla, Neesha Ramchandani, Jeniece Trast, Martin Cantwell, Rubina A Heptulla. J Diabetes Sci Technol 2014
27
7



Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Thomas Fremming Dejgaard, Christian Seerup Frandsen, Tanja Stenbæk Hansen, Thomas Almdal, Søren Urhammer, Ulrik Pedersen-Bjergaard, Tonny Jensen, Andreas Kryger Jensen, Jens Juul Holst, Lise Tarnow,[...]. Lancet Diabetes Endocrinol 2016
72
7


Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis.
Feng Sun, Shanshan Wu, Shuxia Guo, Kai Yu, Zhirong Yang, Lishi Li, Yuan Zhang, Xiaochi Quan, Linong Ji, Siyan Zhan. Diabetes Res Clin Pract 2015
133
7

The role of adjunctive exenatide therapy in pediatric type 1 diabetes.
Vandana S Raman, Kimberly J Mason, Luisa M Rodriguez, Krishnavathana Hassan, Xiaoying Yu, Lisa Bomgaars, Rubina A Heptulla. Diabetes Care 2010
60
7

Incretin-based therapy and risk of acute pancreatitis: a nationwide population-based case-control study.
Reimar Wernich Thomsen, Lars Pedersen, Niels Møller, Johnny Kahlert, Henning Beck-Nielsen, Henrik Toft Sørensen. Diabetes Care 2015
56
7


Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus.
Nitesh D Kuhadiya, Ritu Malik, Natalie J Bellini, Jane Lyons Patterson, Andrea Traina, Antoine Makdissi, Paresh Dandona. Endocr Pract 2013
55
7

Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized Trial.
Thomas Idorn, Filip K Knop, Morten B Jørgensen, Tonny Jensen, Marsela Resuli, Pernille M Hansen, Karl B Christensen, Jens J Holst, Mads Hornum, Bo Feldt-Rasmussen. Diabetes Care 2016
31
7

Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial.
Melanie J Davies, Stephen C Bain, Stephen L Atkin, Peter Rossing, David Scott, Minara S Shamkhalova, Heidrun Bosch-Traberg, Annika Syrén, Guillermo E Umpierrez. Diabetes Care 2016
92
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.